Lysine demethylase 1A alleviates Alzheimer disease progression by regulating the leucine carboxyl methyltransferase 1/protein phosphatase 2 catalytic subunit alpha/transcription factor EB pathway via O‐GlcNAcase‐mediated forkhead box transcription factor A2 O‐GlcNAcylation modification